Antagonism of the complement component C4 by flavivirus nonstructural protein NS1

Journal of Experimental Medicine

Volumn 207, Issue 4, 2010, Pages 793-806

  Avirutnan, Panisadee ^a,b   Fuchs, Anja ^a   Hauhart, Richard E ^a   Somnuke, Pawit ^a,b   Youn, Soonjeon ^a   Diamond, Michael S ^a   Atkinson, John P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C4; LECTIN; NONSTRUCTURAL PROTEIN 1;

ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DENGUE VIRUS; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

ANIMALS; BIOCATALYSIS; CHO CELLS; COMPLEMENT C1; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C1S; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT C3B; COMPLEMENT C4; COMPLEMENT C4B; COMPLEMENT FACTOR I; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; CRICETINAE; CRICETULUS; DENGUE VIRUS; ENZYME PRECURSORS; GUINEA PIGS; HUMANS; KINETICS; NEUTRALIZATION TESTS; PROTEIN BINDING; VIRAL NONSTRUCTURAL PROTEINS;

EID: 77951063838     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20092545     Document Type: Article

References (44)

1. Alcon, S., A. Talarmin, M. Debruyne, A. Falconar, V. Deubel, and M. Flamand. 2002. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40:376-381. doi:10.1128/JCM.40.02.376-381.2002
2. Alcon-LePoder, S., M.T. Drouet, P. Roux, M.P. Frenkiel, M. Arborio, A.M. Durand-Schneider, M. Maurice, I. Le Blanc, J. Gruenberg, and M. Flamand. 2005. The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity. J. Virol. 79:11403-11411. doi:10.1128/JVI.79.17.11403-11411.2005
3. Avirutnan, P., N. Punyadee, S. Noisakran, C. Komoltri, S. Thiemmeca, K. Auethavornanan, A. Jairungsri, R. Kanlaya, N. Tangthawornchaikul, C. Puttikhunt, et al. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193:1078-1088. doi:10.1086/500949
4. Avirutnan, P., L. Zhang, N. Punyadee, A. Manuyakorn, C. Puttikhunt, W. Kasinrerk, P. Malasit, J.P. Atkinson, and M.S. Diamond. 2007. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 3:e183. doi:10.1371/journal. ppat.0030183
5. Avirutnan, P., E. Mehlhop, and M.S. Diamond. 2008. Complement and its role in protection and pathogenesis of flavivirus infections. Vaccine. 26S:I100-I107.
6. Barilla-LaBarca, M.L., M.K. Liszewski, J.D. Lambris, D. Hourcade, and J.P. Atkinson. 2002. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J. Immunol. 168:6298-6304.
7. Björck, L., and G. Kronvall. 1984. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J. Immunol. 133:969-974.
8. Bokisch, V.A., F.H. Top Jr., P.K. Russell, F.J. Dixon, and H.J. Müller-Eberhard. 1973. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N. Engl. J. Med. 289:996-1000.
9. Chung, K.M., M.K. Liszewski, G. Nybakken, A.E. Davis, R.R. Townsend, D.H. Fremont, J.P. Atkinson, and M.S. Diamond. 2006a. West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc. Natl. Acad. Sci. USA. 103:19111-19116. doi:10.1073/pnas. 0605668103
10. Chung, K.M., G.E. Nybakken, B.S. Thompson, M.J. Engle, A. Marri, D.H. Fremont, and M.S. Diamond. 2006b. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80:1340-1351. doi:10.1128/JVI.80.3.1340-1351.2006
11. Clyde, K., J.L. Kyle, and E. Harris. 2006. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J. Virol. 80:11418-11431. doi:10.1128/JVI.01257-06
12. Falconar, A.K. 1997. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142:897-916. doi:10.1007/s007050050127
13. Flamand, M., F. Megret, M. Mathieu, J. Lepault, F.A. Rey, and V. Deubel. 1999. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73:6104-6110.
14. Gigli, I., T. Fujita, and V. Nussenzweig. 1979. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. USA. 76:6596-6600. doi:10.1073/pnas.76.12. 6596
15. Halstead, S.B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science. 239:476-481. doi:10.1126/science.3277268
16. Hortin, G.L., T.C. Farries, J.P. Graham, and J.P. Atkinson. 1989. Sulfation of tyrosine residues increases activity of the fourth component of complement. Proc. Natl. Acad. Sci. USA. 86:1338-1342. doi:10.1073/pnas.86.4.1338
17. Jongerius, I., J. Köhl, M.K. Pandey, M. Ruyken, K.P. van Kessel, J.A. van Strijp, and S.H. Rooijakkers. 2007. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204:2461-2471. doi:10.1084/jem.20070818
18. Khromykh, A.A., P.L. Sedlak, K.J. Guyatt, R.A. Hall, and E.G. Westaway. 1999. Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J. Virol. 73:10272-10280.
19. Krych-Goldberg, M., R.E. Hauhart, V.B. Subramanian, B.M. Yurcisin II, D.L. Crimmins, D.E. Hourcade, and J.P. Atkinson. 1999. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J. Biol. Chem. 274:31160-31168. doi:10.1074/jbc.274.44.31160
20. Krych-Goldberg, M., R.E. Hauhart, T. Porzukowiak, and J.P. Atkinson. 2005. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors. J. Immunol. 175:4528-4535.
21. Lambris, J.D., D. Ricklin, and B.V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6:132-142. doi:10.1038/nrmicro1824
22. Libraty, D.H., P.R. Young, D. Pickering, T.P. Endy, S. Kalayanarooj, S. Green, D.W. Vaughn, A. Nisalak, F.A. Ennis, and A.L. Rothman. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186:1165-1168. doi:10.1086/343813
23. Lin, C.F., H.Y. Lei, A.L. Shiau, C.C. Liu, H.S. Liu, T.M. Yeh, S.H. Chen, and Y.S. Lin. 2003. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J. Med. Virol. 69:82-90. doi:10.1002/jmv.10261
24. Lindenbach, B.D., and C.M. Rice. 1997. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71:9608-9617.
25. Liszewski, M.K., M.K. Leung, R. Hauhart, R.M. Buller, P. Bertram, X. Wang, A.M. Rosengard, G.J. Kotwal, and J.P. Atkinson. 2006. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J. Immunol. 176:3725-3734.
26. Liszewski, M.K., C.J. Fang, and J.P. Atkinson. 2008. Inhibiting complement activation on cells at the step of C3 cleavage. Vaccine. 26(Suppl 8): I22-I27. doi:10.1016/j.vaccine.2008.11.001
27. Mackenzie, J.M., M.K. Jones, and P.R. Young. 1996. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology. 220:232-240. doi:10.1006/viro.1996.0307
28. Mehlhop, E., K. Whitby, T. Oliphant, A. Marri, M. Engle, and M.S. Diamond. 2005. Complement activation is required for induction of a protective antibody response against West Nile virus infection. J. Virol. 79:7466-7477. doi:10.1128/JVI.79.12.7466-7477.2005 (Pubitemid 40756783)
29. Morens, D.M., and A.S. Fauci. 2008. Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA. 299:214-216. doi:10.1001/jama.2007.31-a
30. Morgan, P.H., and I.G. Nair. 1975. Autocatalytic activation of the proenzyme form of the C1s subunit of the first component of complement. Biochem. Biophys. Res. Commun. 66:1037-1041. doi:10.1016/0006-291X(75)90744-5
31. Nimmannitya, S. 1987. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J. Trop. Med. Public Health. 18:392-397.
32. Oleszak, E.L., S. Perlman, R. Parr, E.W. Collisson, and J.L. Leibowitz. 1993. Molecular mimicry between S peplomer proteins of coronaviruses (MHV, BCV, TGEV and IBV) and Fc receptor. Adv. Exp. Med. Biol. 342:183-188.
33. Para, M.F., R.B. Baucke, and P.G. Spear. 1982. Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors. J. Virol. 41:129-136.
34. Park, S.Y., Y.P. Shin, C.H. Kim, H.J. Park, Y.S. Seong, B.S. Kim, S.J. Seo, and I.H. Lee. 2008. Immune evasion of Enterococcus faecalis by an extracellular gelatinase that cleaves C3 and iC3b. J. Immunol. 181:6328-6336.
35. Patkar, C.G., and R.J. Kuhn. 2008. Yellow Fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J. Virol. 82:3342-3352. doi:10.1128/JVI.02447-07
36. Puttikhunt, C., W. Kasinrerk, S. Srisa-ad, T. Duangchinda, W. Silakate, S. Moonsom, N. Sittisombut, and P. Malasit. 2003. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J. Virol. Methods. 109:55-61. doi:10.1016/S0166-0934(03)00045-4 (Pubitemid 36355886)
37. Rooijakkers, S.H., M. Ruyken, A. Roos, M.R. Daha, J.S. Presanis, R.B. Sim, W.J. van Wamel, K.P. van Kessel, and J.A. van Strijp. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6:920-927. doi:10.1038/ni1235
38. Rosengard, A.M., Y. Liu, Z. Nie, and R. Jimenez. 2002. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. USA. 99:8808-8813.
39. Ryman, K.D., C.L. Gardner, C.W. Burke, K.C. Meier, J.M. Thompson, and W.B. Klimstra. 2007. Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J. Virol. 81:3563-3573. doi:10.1128/JVI.02494-06
40. Schenkein, H.A., H.M. Fletcher, M. Bodnar, and F.L. Macrina. 1995. Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins. J. Immunol. 154:5331-5337.
41. Schlesinger, J.J., M.W. Brandriss, and E.E. Walsh. 1985. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol. 135:2805-2809.
42. Thielens, N., and G.J. Arlaud. 2000. C1s. In The complement facts book. B.J. Morley, and M.J. Walport, editors. Acedemic Press, London. 56-60.
43. von Pawel-Rammingen, U., and L. Björck. 2003. IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. Curr. Opin. Microbiol. 6:50-55. doi:10.1016/S1369-5274(03)00003-1 (Pubitemid 36258536)
44. Ziccardi, R.J. 1982. A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement. J. Immunol. 128:2505-w.